immunizations with the strain of origin, no alloantibody was detected (12, 33, 34) , and this contrasts strongly to the ease with which T cell reactions are elicited.
We now report studies of the specificity of the cytotoxic T lymphocytes (CTL) generated in MLC in all possible combinations between seven Kb-locus mutants and the wild type H-2 b, as measured by CML. Three new K b mutants (H-2 brag, H-2 bin1°, and H-2 bin11) showed positive MLC and CML reactions with the strain of origin. Two mutants (H-2 bin6 and H-2 bmg) were found to be identical in CML. The analysis of CML cross-reactivity against third-party targets of the K b series indicated extensive complexity of K b CML target-antigenic determinants. Apparently, single AA substitution in the K b molecule leads to the loss of multiple CML target determinants and gain of multiple new CML target determinants. In this study, 64 different CML target specificities were identified, 19 of which have been described before (25, 35, 36) . The CML antigens of the bm3 mutation, which has two AA substitutions in its K b glycoprotein, were closely related but not identical to those of the bm 11 mutation, which shares its AA substitution with one of the two AA substitutions of bm3 (see above: B. M. Ewenstein et al. Manuscript in preparation).
Materials and Methods
Animals. All mice were bred at the Central Laborator~ of the Netherlands Red Cross Blood Transfusion Service, Amsterdam. C57BL/6Kh (B6, H-2~ mice as well as the mutants B6-H-2 bin6, B6-H-2 bms, B6.C-H-2 brag, B6.C-H-2 brat°, and B6.C-H-2 bran were raised from breeding stocks, supplied by Dr. H. I. Kohn and Dr. R. W. Melvold, Shields Warren Radiation Laboratory, Boston, Mass. B6.C-H -bin1 mice were bred from stocks supplied by Dr. Donald Bailey, The,Jackson Laboratory, Bar Harbor, Maine. Breeding stock of the B6-H-2 bin3 line was obtained from Dr. J. Klein, then at the Department of Microbiology, University of Texas, Dallas, Tex. A list of the H-2-mutant lines used and references to their first description are given in Table I .
Preparation of Cell Suspensions. Cell suspensions were prepared from lymphoid organs as described previously (25) with minor modifications. Spleen or lymph node cells were mixed and pressed through stainless metal sieves into RPMI-1640 medium with 25 mM Hepes buffer and 2 mM L-glutamine, containing 10% fetal calf serum (FCS, heat-inactivated for 30 min at 56°C; Grand Island Biological Co., Grand Island, N. Y.). This cell suspension was washed twice in the same medium.
Generation of Killer Cells in MLC.
Spleen cells were resuspended in culture medium consisting of RPMI-1640 with 25 mM Hepes buffer and 2 mM L-glutamine plus 100 IU penicillin and 100 /~g streptomycin/ml, supplemented with 10% heat-inactivated (30 min, 56°C) human serum and containing 2-mercaptoethanol to a final concentration of 2 × 10 -5 M. This cell suspension was used as the responding population in MLC. Viable responder cells (100 × 106) were mixed with 100 × 106 stimulator cells (irradiated with 2,500 rad from a X3VCs source) in a 250-ml culture flask (Costar, Data Packaging, Cambridge, Mass.; catalog No. 3075) that contained 80 ml of culture medium. The flasks were tilted at a 45 ° angle to allow the cells to settle in one corner, and incubated at 37°C, after which the cells were harvested.
CML. After a total of 5 d of culture as described above, the cells were used as effector cells in CML assays. The culture supernate was removed, the cells were washed twice, and were resuspended in medium consisting of RPMI-1640 with 25 mM Hepes, supplemented with 10% heat-inactivated (30 min, 56°C) FCS.
Target cells for CML were obtained by culturing lymph node cells for 48 h in the presence of concanavalin A (2.5 /zg/ml of culture medium). After one wash, 10 × 10 ~ target cells, suspended in 1 ml of wash medium, were incubated for 30 min at 37°C with 150/zCi Na2-[51Cr]O4 (sp act: 50-400 mCi/mg 51Cr, The Radiochemical Centre, Amersham, England). Then the cells were washed three times and resuspended in medium with 10% heat-inactivated FCS.
The CML assays were performed in microtiter plates with round-bottomed wells (Cooke Additional details about these mutants have been published (19) .
Engineering Co., Alexandria, Va.). Target cells (1 X 105) were mixed with varying numbers of effector cells in a total vol of 0.2 ml. The plates were incubated for 3 h at 37°C in humidified air with 5% COz. Subsequently, the plates were centrifuged at 700 g for 10 min. Next, 100 #1 of the supernate was removed and transferred to a 70-X 11-mm plastic tube. The radioactivity in this tube was determined in a gamma scintillation counter, and the specific 51Cr release (r) was calculated using the formula:
where e is the 51Cr release (counts per minute) in the experimental tube, b the background 51Cr release, and s the maximal release in the presence of 5% saponin. Background release was taken to be the 5aCr release seen in the presence of syngeneic nonactivated, cultured cells. For example, the background release for target cells from mouse strain A was the release seen after incubation of A target cells with A + A irradiated effector cells. The background release was always <23%, the maximal release varied from 82 to 100% crude lysis. All assays were performed in triplicate. The standard error of triplicate tests was always <3% specific lysis.
Determination of Lymphocyte Activation in MLC. Responding and stimulating cells from the same cell suspensions used for the generation of killer cells were each brought to a concentration 6f 5 × 106/ml. 100 #1 of responding and 100 #1 of stimulating cells were transferred to each well of a round-bottomed microculture plate (Cooke Engineering Co.). After 3 d of culture at 37°C in humidified air with 5% COz, 20 pl [3H]thymidine (Amersham Corp., Arlington Heights, Ill.; 200 mCi/mmol, 20 #Ci/ml) was added. The cultures were harvested 24 h later, and [3H]thymidine incorporation was determined as described previously (26) . All determinations were performed in triplicate.
Results

CML Reactions of Three New K b Mutants.
Three new Kb-locus mutants, all discovered by skin graft rejection and proven to be gain/loss mutations of the K b locus (15, 19) were tested in CML after MLC with the strain of origin, C57BL/6. The results are shown in Table II .
As observed with all previously studied Kb-locus mutants, CML was strongly positive in both directions (Table II) , illustrating the gain/loss nature of these mutations. Proliferative responses in MLC were also positive in both directions (Table  II) .
Kinetics ofCML: CML Cross-Reactivity. The definition of CML target determinants specified by the mutations largely depends on the phenomenon of cross-reactivity, i.e., lysis of target cells of genotypes other than those of the stimulator or responder cell in MLC (third-party targets). stimulator-or responder-cell genotypes and against third-party targets is shown in Fig. 1 . The effector-cell number was varied while the target-cell number was kept constant.
Although strongest lysis was seen against targets of stimulator-cell genotype, extensive cross-killing of third-party targets occurred. Target cells of responder-cell genotype were,not lysed (Fig. 1) .
CML after MLC with Homozygous Responder Cells in All Possible Combinations of Seven K b Mutants and the Wild-Type H-2 b.
On the basis of the results shown in Fig. 1 and similar results with other cell combinations (data not shown), an effector-cell number of 2 × 105 was selected for optimal detection of the various levels of cross-reactivity.
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The results of CML tests after MLC with homozygous responder cells are shown in Table III . This analysis includes all possible unilateral MLC combinations between 7 Kb-locus mutants and the strain of origin (B6-H-2b). Table III shows that lysis of target cells of MLC responder genotype never exceeded 10%. Therefore, a CML result was scored as positive when -->15% specific lysis occurred. With most MLC combinations, cross-killing of third-party targets was extensive, but Usually the specific lysis of these targets fell below that of targets of stimulator-cell genotype. These results indicate CML specificity for target determinants of stimulator-cell genotype and extensive sharing of CML determinants between stimulator cells, and third-party targets. Solid line boxes indicate lysis against target cells of responder :genotypes (Table III) . Broken line boxes indicate the only MLC T/~IGL~ CELl TO.
H-2 combinations in which no killer cells were generated: bm6-anti-bm9 and vice versa (Table III) . This indicates that bm6 and bm9 are identical for CML determinants. This notion is supported by the finding that all effector-cell combinations kill bin6 and bm9 to a similar extent. Moreover, the CML killing patterns, observed with bin6 as stimulator or responder in MLC, were virtually identical to those observed with bin9 stimulator or responder cells (see below, Designation of CML Determinants; Relatedness among Different K b Mutants).
CML after MLC with Ft Hybrid Responder Cells in All Possible MLC Combinations of Four K b Mutants and the Wild-Type H-L #.
Previous studies have indicated that CML crossreactivity against third-party targets can be eliminated by introducing the third-party genotype into the responder cell, i.e., by using F1 hybrid responder cells (25) . The results of a series of CML experiments with F1 hybrid responders in MLC are shown in Table IV . This analysis includes all possible MLC combinations with F1 responders among four K b mutants (bml, bin3, bin6, and bin8) and the wild-type H-2 b. Table IV shows that lysis of target cells from a parent of the F1 hybrid responder was sometimes slightly higher than that of responder type targets in the case of homozygous responders (Table III) , but never exceeded 18% specific lysis. A CML result achieved with Fa hybrid responding cells was scored as positive when >--20% specific lysis occurred. According to this criterion, a positive CML result was at least 11% specific lysis above the highest background lysis against parental-type targets seen with the same effector cell (Table IV) .
In all MLC combinations, strong cytotoxicity was generated against ceils of stimulator-cell genotype. Cross-killing against targets of the partner in the Fa responder was eliminated, but cross-reactivity against other targets was still seen, though to a lesser extent than with homozygous MLC responders. In a previous study, strong specific cytotoxicity was reproducibly observed against target cells from one of the parents of two Fx responders: (b X bml)F1 responder and (b × binS)F1 responder X X X X X X X X X X XX X X X X X X x.~ g~ stimulated by bm5 or bm6 lysed not only bm5 or bm6 but also b targets (25) . Subsequent analysis has revealed that these anomalous F1 anti-P CML reactions were a result of segregation of a bm5/6-1ike mutation in the H-2 b stock used for raising these F1 hybrids (C. J. M. Melief et al. Unpublished observations.). This has led to the identification of the first H-2 mutant picked up by CML, that was provisionally named KB-96 (19) . In our study, in which H-2 b stock that was free of the bmS/6-1ike mutation was used for raising F1 hybrids, these anomalous CML reactions were no longer seen (Table IV) .
Designation of CML Determinants. The methodology by which CML determinants are identified has been published (25, 35, 36) . If a particular MLC effector-cell combination lyses target cells of stimulator-cell genotype, then that target cell, and any other target cell killed to a similar extent, are considered to express determinant X. Target cells that are killed less intensely but still above background are considered to partially express determinant X, designated as (X). Target cells that are not killed are considered to lack the relevant antigenic determinant. We have arbitrarily defined expression of CML determinants as follows: ABSENCE OF DETERMINANT. Lysis below threshold levels of positivity. These levels are 15% specific lysis (homozygous responders, section 3, Table III ) and 20% specific lysis (F1 hybrid responders, section 4, (24, 25) . The remaining 16 determinants were identified in our laboratory. The designation of 15 of these and their expression on 4 K b mutants and the strain of origin, B6-H-2 b, have been published (25) . Table V shows the expression of the first 20 determinants in seven Kb-locus mutants and B6-H-2 b. Each determinant is defined by at least one MLC effector combination (Tables III and IV) . Further analysis of the CML data of Tables III and IV allowed  the designation of 44 new determinants (determinants 26-69, 2 Table VI) . In four instances, two patterns of expression of a particular determinant were distinguished (determinants 2, 5, 9, and 29; a and b). In three of these cases (determinants 2, 9, and 29; a and b), a slight difference of expression was found when either bin6 or bm9 stimulators were used in MLC. Because of the strong evidence that bm6 and bm9 are identical (Discussion), the difference in expression between determinant a and determinant b was likely a result of technical variability. In the fourth case (determinant 5), (bml × bm3)F1 anti-b effector cells showed the same CML reaction pattern as (bm 1 × bm3)F1 anti-bm6 effector cells, except for bm 10 target cells, which showed full and partial expression of the relevant determinant, respectively. Because the reactions against bml0 target were only performed once (Table IV) and could not be repeated because of the lack of available mice, the 5a and 5b determinants are considered identical until proven otherwise.
z CML determinants 21-25 were defined by J. Klein on the H-2 haplotypes f, fmb k, and kml (37) . Relatedness among Different K b Mutants. Two pairs of mutants showed complete (bm6 and bm9) or extensive (bm3 and bml 1) sharing of CML determinants. Sharing of determinants or common absence of a determinant is indicated by boxes in Tables V and VI. The identity of bm6 and bin9 for all CML antigens is in agreement with the observation that CML between these two strains is negative (section 3, Table III) and that skin grafts exchanged between these mutants are permanently accepted (R. W. Melvold. Unpublished observations.).
The mutants bm3 and bm 11 are closely related although not identical with respect to CML antigens (Tables V and VI) . This relationship is also reflected in the finding that most MLC combinations with either bm3 or bm 11 stimulator cells yielded strong CML activity against both types of target cells (Tables III, V, and VI) . Furthermore, CML generated in reciprocal MLC between these two mutants showed little (bm 11 anti-bm3) or no (bin3 anti-bml 1) cross-reactivity against third-party targets (Tables  III, V , and VI; specificities 47 and 33). A complete absence of CML cross-reactivity was not observed with any other MLC combination. The nonidentity of bm3 and bml 1 is in agreement with the observation that these mutants rapidly reject each others skin grafts (R. W. Melvold. Unpublished observation.). Tables V and VI , it was determined to which extent each mutant differed from the strain of origin (H-2 b) by scoring antigen matches and mismatches. In addition, it was determined how many antigens were commonly lacking in both mutant and H-2 b"
Distance of Each K b Mutant frorn H-2 b. From the CML antigen chart presented in
Matching was performed in two ways. First, by matching only for those CML antigens defined by MLC with homozygous responders. Second, by matching in addition for those antigens defined by MLC with F1 hybrid responders.
The mutants bm9, bml0, and bmll were excluded from the second analysis, because in the distinction of CML determinants by F1 hybrid responders, they were not used as stimulators nor as one of the parents of the F1 hybrid responder. The results of both ways of CML matching with H-2 b are shown in Table VII A and B. Table VII shows that from the total number of matches and mismatches the sequence of relatedness with H-2 b is as follows: bm6/bm9-bml0-bm3-bm8-bmlbml 1; bin6 and bin9 being the closest to H-2 b. The two mutants differing most from H-2 b, bml and bml 1, do not share a single fully expressed determinant with H-2 b, whereas all other mutants share one to eight fully expressed determinants with H-2 b. H-2 bmll appears to differ most from H-2 b, not only because it shows the largest total number of mismatches with H-2 b, but also because seven of these mismatches are of the + ~ -type versus only two mismatches of this type in the H-2 bm~ mutant. The chart of the first 20 K b CML specificities, arrived at during the 1978 H-2 mutant workshop (19) , was confirmed with minor modifications and the three new mutants were typed for these determinants (Table V) . In addition, 44 new K b CML determinants were~identified and all seven available K b mutants were typed for these determinants (Table VI) .
As discussed previously (23-25, 35, 36) , homozygous MLC responders in many instances react to multiple CML determinants. This is illustrated by comparing CML by homozygous responders with CML by F1 hybrid responders in MLC. For example, b anti-bm8 effector cells kill not only bin8 target cells, but also target cells from all other haplotypes except that of the MLC responder (determinant 18, Table V) . Effector cells Co × bml)F1 anti-bm8 kill the same targets except for the reaction against bml which is eliminated (determinant 19, Table V) . A further reduction of cross-kill is seen with Co × bm6)F1 anti-bm8 effector cells (determinant 20, Table V) in which, apart from bin8, only bml0 and bml 1 targets are lysed. Therefore, b antibm8 effector cells recognize at least three CML determinants: one present on bm8 and partially shared by all other mutants (determinant 18, Table V), a second expressed on bm8 and bm3 and partially expressed on all other mutants with the exception of bml (determinant 19, Table V) , and a third expressed on bm8 and partially on bml0 and bml 1 (determinant 20, Table V) . Cross-killing against thirdparty targets can also be eliminated by adsorption to third-party monolayers (36) but, like the use of F1 hybrid responders, this approach is unlikely to eliminate all cross-killing, unless multiple subsequent absorptions are done. This follows from the following set of data. Effector cells bm 1 anti-b kill not only b target cells, but also targets from all other mutant lines except bml (determinant 1, Table V) . Geib et al. (36) have shown that the cross-reactivity against bm3 can be eliminated by absorbing bm 1 anti-b effector cells to bin3 monolayers (determinant 5, Table V) . Determinant 5 was found to be unique for b of the targets tested (b, bm 1, and bin3). We achieved the same result using (bm 1 × bm3)Fx responders (determinant 5, Table V) . However, when the other targets were tested, (bin 1 × bin3) anti-b effector cells still lysed bm6, bm9, and bm 10 targets and to a smaller extent, bm8 and bm 11 targets (Table V) . It can be predicted that bml anti-b effectors absorbed to bm3 monolayers show the same killing pattern.
The F1 hybrid and absorption experiments indicate that multiple clones of CTL are generated, but the actual number and specificity of all CTL clones generated in a given MLC can best be studied by producing monoclonal cytolytic T-cell lines (39) (40) (41) . The possibility that even in MLC with F1 responders multiple CML determinants are recognized indicates that the current chart of determinants is only an approximation of the actual situation. The complexity of K b CML determinants calls for a mathematical model by which the CML reaction patterns can be analyzed in a systematic fashion. Recently, such a model was developed by Wohlgemuth (42) and was applied to the data from which the first 19 CML determinants were deduced (43) .
Although development of monoclonal cytolytic T cell lines as CML-typing reagents and mathematical analysis of the system of K b CML determinants can be expected to enhance our insight into the organization of this complex immunogenetic system, the current chart of determinants is operationally useful for a number of deductions. First, the chart of determinants allows conclusions concerning the functional relat-edness among different mutants and concerning the correlation function/structure. The mutants bm6 and bm9 show identical typing for all 64 CML determinants (Tables V and VI) . Two sets of additional data indicate that bm6 and bm9 are indeed identical. CML between these two mutants is negative in both directions (Table III) and both mutants share AA substitutions in the K b molecule (see above: K. Yamaga et al. Unpublished observations.). Three other K b mutants are phenotypically identical with bm6:bm5 and bm7 and the K b mutant picked up by CML, KB-96 (19) . Together, these mutations form the bg-series. (The bm5, bm6, and bm7 mutations were formerly called bgl, bg2, and bg3, respectively [19] ).
The close relationship of the mutants bm3 and bml 1 with respect to CML determinants (Tables V and VI) (Table III) . Also, it might be expected that bm3 with two AA substitutions differs more from H-2 b than bm 11 with only one AA substitution. The actual analysis of relatedness indicates, however, that bm 11 differs more from H-2 b than does bm3 (Table VII) . These findings could signify that CML determinants reflect tertiary protein structure rather than direct AA sequences. Thus, the effects of the AA substitutions on the CML specificities are difficult to predict.
The sequence of relatedness of the mutants bm6, bm3, bmS, and bml with H-2 b (Table VII) is the same as that published earlier (25) , except that it is now clear that bm3 differs more from H-2 b than does bm6. In studies on the role of the K b molecule in associative recognition and lysis of virus-infected target cells by virus-specific T cells, it was found that the difference b ~ bm 1 completely precluded lysis in T celltarget combinations that shared all other genes in the K, I-A, or I-B regions of the H-2 complex (28, 29) . In case of a b ~ bm8 or b ~ bm5/6 difference, target-cell lysis was impaired but not prevented (29) . We have noted earlier that these findings correspond with the relatedness sequence by CML typing with alloreactive T cells (25) .
At first sight, it seems unexpected that the difference b ~ bm 1 completely precludes H-2K-restricted killing in the virus systems, because bml shares 10 matches with H-2 b (Table VII) . However, there is not a single match for fully expressed determinants of the type + ~-~ + between b and bm 1 (Table VII) , whereas bm8 and bm6 show one and five such matches, respectively. A match for partially expressed determinants of the type (+) ~ (+) (Table VII) does not necessarily indicate antigenic identity because the partial lysis could be directed against different portions of the fully expressed determinant(s) or against altered determinants. As a working hypothesis, we postulate that for the specificity of H-2 restriction in virus-directed T cell killing, matching for fully expressed determinants, recognized by alloimmune CTL, is crucial, whereas matching for partially expressed determinants is not important. The hypothesis predicts that in H-2K-associated killing by virus-directed T cells, a more complete failure to lyse would be seen with the combinations b ~ bml and b ~ bml 1, than with the other b *-~ b mutant combinations, a hypothesis which remains to be tested with the bml 1, bm3, bm9, and bml0 mutants, but so far holds for the bml, bm5/6, and bm8 mutants (29) . This hypothesis implies that at least some of the CML determinants recognized by alloreactive CTL are identical to the H-2 determinants involved in associative recognition by virus-directed T cells, as postulated elsewhere (44) . Different compatibility requirements prevail in H-2-associated recognition of trinitrophenyl (TNP)-modified targets, where b ~ bm 1 or b ~ bm3 differences between attackers and targets did not preclude H-2K-associated lysis (45) , in contrast to the virus system. Perhaps in T cell killing of TNP-modified targets, the sharing of partially expressed determinants is sufficient.
That limited AA changes in the K b molecule have such drastic effects on K bdirected alloreactivity points out how sensitive the T lymphocyte system is to subtle changes in the K b molecule. Indeed, the complexity at the target-cell and receptor levels reported here may be a reflection of the important biological role of this category of H-2 molecule in associative recognition and elimination of virus-infected cells (5-7). In addition, this complexity may help to explain the observation that virus-directed cytotoxic T lymphocytes cross-react with alloantigens (46, 47) .
Recently, it was argued that anti-H-2 CTL are less specific than the H-2-restricted response to the male antigen H-Y, because they show more cross-reactivity (48) . However, the intensity of killing in the anti-H-2 response was in many instances greater than in the anti-H-Y response. Therefore, cross-reactivity may have been less conspicuous in the anti-H-Y system. Also cross-killing in the anti-H-Y response might show up if more haplotypes were tested.
The availability of the K b series of mutants has allowed recognition of individual determinants by exquisitely specific CTL. The extensive cross-reactivity appears to indicate complexity, not lack of specificity. Comparison with the biochemical analysis of Brown and Nathenson (20) 
Summary
The fine specificity of alloimmune cytotoxic T lymphocytes (CTL) was investigated in CTL responses across the smallest known H-2 differences, those based on mutation at a single H-2 locus. CTL were generated in all possible mixed lymphocyte culture (MLC) combinations among seven H-2K b mutants and the mouse strain of origin, C57BL/6 (B6-H-2b). CTL were also generated in all F1 hybrid responder/homozygous stimulator-cell combinations among four K b mutants and B6-H-2 b. CTL activity was measured in cell-mediated lympholysis (CML) against target cells from all K b mutants and B6-H-2 b. Cross-reactivity against targets other than the MLC stimulator was extensive and led to the distinction of 64 CML target determinants. Two K b mutants (B6-H-2 bm6 and B6.C-H-2 bma) showed identical typing for all 64 CML determinants. CML reactions after MLC between these two haplotypes were mutually negative. The mutants B6-H-2 bins and B6.C-H-2 bmxl showed identical typing for 47 of the 64 determinants. Their close relationship is in agreement with the finding that H-2 bin3 anti-H-2 bran CTL were the only ones that exclusively lysed target cells of stimulatorcell genotype.
On the basis of CML typing, the sequence of relatedness of the mutants with H-2 b is as follows: bm6/bm9-bml0-bm3-bm8-bml-bml 1, bm6/bm9 being the closest to, and bm 11 the most distant from H-2 b. The extensive cross-reactivity of alloimmune CTL appears to reflect immunogenetic complexity rather than lack of specificity. Comparison with other reports supports the notion that the system of K b CML determinants, recognized by alloimmune CTL, is at least partially overlapping with the H-2K b specificity repertoire involved in the associative T cell recognition of virusinfected cells.
